Las acciones de Abbott Laboratories están respaldadas por un largo historial de dividendos y un reciente crecimiento en sal en el segundo trimestre de 2026.

Los analistas siguen elevando sus objetivos de precios en este aumento de dividendos a 54 años. Estas son las razones detrás de la nueva confianza.

Información detallada de precios para Citigroup Inc (C-N) de The Globe and Mail, incluidos gráficos y operaciones.

Settlement Reached: Social media chatter has centered on Abbott Laboratories agreeing to a roughly $

Settlement Reached: Social media chatter has centered on Abbott Laboratories agreeing to a roughly $

The hit to formula supply had already become a national crisis.

A $385 million settlement will resolve claims stemming from Abbott Laboratories' Sturgis, Michigan, baby formula plant, whose 2022 shutdown amid contamination concerns helped set off a nationwide shortage.

Abbott's board announced a quarterly dividend of 63 cents per share, payable on November 16, 2026, to shareholders recorded by October 15, 2026. This marks Abbott's 411th consecutive quarterly dividend since 1924 and continues its streak of 54 years of annual dividend increases. Abbott is recognized as a Dividend Aristocrat, reflecting its strong commitment to returning value to shareholders. The company remains a global leader in healthcare with a diverse portfolio serving over 160 countries.

Abbott’s Baby-Formula Settlements Top $1 Billion as U.S. Pediatric Sales Fall 11% - TechStock²

Under the settlement, Abbott will pay $384,999,040 to resolve allegations under the False Claims Act.

The payment is part of a $385 million settlement between the company and federal and state governments.